Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210027978 210038741 1.82 84.2 Curative (C) 2016-07-13 2016-07-27 Dasatinib N N 210041618 DASATINIB
210027979 210013592 1.56 60.7 Palliative (P) 2019-02-15 2019-07-25 CYCLOPHOSPHAMIDE N N 210041621 CYCLOPHOSPHAMIDE
210027980 210013595 1.71 0 null 2018-03-04 2018-03-31 UKALL XII Maintenance (3 months) 02 N 210041626 INOTUZUMAB OZOGAMICIN
210027981 210022495 1.74 null Curative (C) 2014-04-19 2014-09-23 Cyclophosphamide+Fludara+TBI Allo N N 210041630 CYCLOPHOSPHAMIDE + FLUDARABINE
210027982 210013600 1.83 102.3 Curative (C) 2016-06-16 2016-07-18 Procarbazine null N 210041637 PROCARBAZINE
210027983 210033677 0 75.3 Curative (C) 2017-07-18 2018-03-15 Dasatinib N N 210041643 DASATINIB
210027984 210022498 1.63 27.4 Curative (C) 2017-02-15 2017-02-15 Vinblastine weekly 2 N 210041654 VINBLASTINE
210027985 210013604 1.88 106.75 Not known (9) 2017-03-17 2017-03-17 Dasatinib 2 N 210041679 DASATINIB
210027986 210022500 null 72.8 Palliative (P) 2019-07-23 2019-07-24 R GCVP 02 N 210041680 BEVACIZUMAB
210027987 210013608 null 101 Palliative (P) 2018-07-05 2018-08-29 Cyclophosphamide oral N N 210041701 CYCLOPHOSPHAMIDE
210027988 210013609 1.6 null Curative (C) 2013-11-06 2013-11-16 IDELALISIB 02 N 210041709 CHLORAMBUCIL + OFATUMUMAB
210027989 210013611 1.75 0 Palliative (P) 2017-05-21 2018-01-16 IDELALISIB N N 210041726 BENDAMUSTINE
210027990 210035154 null 99.7 Curative (C) 2014-06-24 2014-11-25 Vinblastine weekly Y N 210041774 VINBLASTINE
210027991 210013613 1.82 87.5 Adjuvant (A) null 2014-01-07 Brentuximab 2 null 210041789 CLOFARABINE + CYTARABINE
210027992 210013615 1.71 64.4 Disease modification (D) 2014-06-20 2014-06-20 Fludarabine IV 02 N 210041797 BEVACIZUMAB + IRINOTECAN
210027993 210036193 1.67 87.4 Adjuvant (A) 2016-02-07 2016-08-01 Cytarabine intrathecal N null 210041807 CARBO + ETOPOSIDE + VINCRISTINE
210027994 210013616 null null Neo-adjuvant (N) 2017-05-22 2017-06-02 Bortezomib (weekly) 02 N 210041810 DOXORUBICIN
210027995 210013620 1.66 21.3 Palliative (P) 2019-04-14 2019-04-14 DAUNORUBICIN + VINCRISTINE 02 N 210041817 CISPLATIN + VINORELBINE
210027996 210013624 1.65 79.75 Disease modification (D) 2016-01-05 2016-10-03 Bevacizumab + LOMUSTINE 2 null 210041820 CVP
210027997 210013627 1.57 78 Adjuvant (A) 2015-10-10 2015-10-16 CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine N N 210041854 R CODOX-M/ R IVAC
210027998 210028117 1.7 66.8 Curative (C) 2015-11-24 2015-11-30 Cytarabine low (10to20mg/m2) IV/SC 02 N 210041861 OFATUMUMAB
210027999 210013633 1.76 null Adjuvant (A) 2014-04-18 2014-08-15 BR14 TRIAL 2 N 210041863 IRINOTECAN + TEMOZOLOMIDE
210028000 210013635 1.64 65.3 Curative (C) 2014-12-22 2014-12-22 Alemtuzumab + Cyclophos TBI Allo N Y 210041872 GEMCARBO
210028001 210028119 1.63 64 Curative (C) 2016-04-06 2016-04-06 Brentuximab Vedotin 99 N 210041872 BEVACIZUMAB + IRINOTECAN
210028002 210028119 1.83 84.2 Disease modification (D) 2018-05-09 2018-05-09 Docetaxel 75mg/m2 (21 day) N N 210041872 CYTARABINE HD + METHOTREXATE HD
210028003 210013639 null 72.3 Curative (C) 2015-12-18 2016-03-08 CARBOPLATIN + VINORELBINE N N 210041935 CISPLATIN + VINORELBINE + RT
210028004 210013640 1.61 63.1 Curative (C) 2015-06-04 2015-07-12 FCR IV - Cycle 2 onwards Y null 210041947 CVP
210028005 210013641 1.79 63.05 Adjuvant (A) 2018-10-06 2018-12-08 Bortezomib + Cyclophos + Dex 2 N 210041947 BEVACIZUMAB + TEMOZOLOMIDE
210028006 210022519 0 82.2 Neo-adjuvant (N) 2018-08-21 2018-10-07 Cytarabine low (10to20mg/m2) IV/SC Y N 210041971 DHAP - R
210028007 210035157 1.73 null Curative (C) 2017-12-29 2017-12-29 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE N null 210041981 ICE
210028008 210013643 1.75 null Curative (C) null 2018-01-30 CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine N N 210041983 FEC
210028009 210022521 null 75 Adjuvant (A) null 2015-09-29 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 210042007 ABVD
210028010 210013646 0 57.2 Curative (C) 2016-12-03 2017-01-14 PENTOSTATIN + RITUXIMAB N N 210042028 CAPECITABINE + CISPLATIN + RT
210028011 210013648 null 12.7 Curative (C) 2015-03-29 2015-04-04 Cytarabine High Dose N null 210042033 TAMIGA TRIAL
210028012 210022524 null null Curative (C) 2018-10-06 2018-10-07 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE Y null 210042039 BEVACIZUMAB + TEMOZOLOMIDE + RT
210028013 210022524 1.76 null Curative (C) 2017-02-17 2017-08-04 TRASTUZUMAB N N 210042039 CISPLATIN + LOMUSTINE + VINCRISTINE
210028014 210013651 null null Curative (C) 2015-09-04 2015-11-26 ICE (no GCSF) Y N 210042045 PEMBROLIZUMAB
210028015 210022525 1.8 76.45 Curative (C) 2014-04-08 2014-04-14 ALL UKALL2003 C: Ph VII Maintenance 01 N 210042045 POMALIDOMIDE
210028016 210022527 null 18.1 Curative (C) 2017-01-18 2017-01-18 CARBOPLATIN + LOMUSTINE + VINCRISTINE N null 210042056 PACKER INDUCTION VINCRISTINE + RT
210028017 210013654 1.68 135 Palliative (P) 2015-01-26 2015-02-05 Lenalidomide 15mg (Cycle 1 to 25) N null 210042059 UKALL 60+ TRIAL
210028018 210013656 1.89 null Curative (C) 2015-12-22 2016-02-05 TAMIGA trial N null 210042061 CODOX M
210028019 210028131 null 50 Curative (C) 2015-02-20 2015-03-03 CYCLET N N 210042066 BEVACIZUMAB + LOMUSTINE
210028020 210028132 null 61.9 Curative (C) 2016-08-04 2016-08-05 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE N N 210042069 CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE
210028021 210013661 1.68 64 Curative (C) 2017-07-09 2017-07-09 FLUOROURACIL + IRINOTECAN 02 N 210042072 DABRAFENIB + TRAMETINIB
210028022 210013662 1.74 33.2 Curative (C) 2014-10-21 2014-10-26 Bevacizumab + LOMUSTINE Y N 210042107 EURO-EWING
210028023 210013662 1.73 null null 2018-02-27 2018-03-02 IPILIMUMAB + NIVOLUMAB null N 210042107 IRINOTECAN + TEMOZOLOMIDE
210028024 210013663 1.83 88.7 Curative (C) 2016-07-30 2016-08-02 Fludarabine + Melphalan RIC Allo N N 210042133 SUNITINIB
210028025 210013663 1.75 null Curative (C) 2014-02-16 2014-02-16 R CODOX M N N 210042133 IRINOTECAN + TEMOZOLOMIDE
210028026 210013665 null 69.3 Curative (C) 2017-11-26 2017-12-27 Cyclophosphamide High Dose 02 null 210042147 ICE
210028027 210013670 1.77 70.2 Curative (C) null 2016-09-28 DA 3 + 10 N N 210042153 GEMCARBO